Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products

Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2021-06-01. On CanQuery you can follow the original downloads. Files are available in English and French.

This Notice serves to inform sponsors of drug submissions pursuant to Division C.08 of the Food and Drug Regulations (that is [i.e.], new drug and abbreviated new drug submissions) of changes in Health Canada's comparative bioavailability requirements for drug products which exhibit large pharmacokinetic within-subject variation in extent of absorption, as measured by area under the concentration versus time curve (AUC).

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-06-01

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data